Well I hope so as recce form 15% of my portfolio. If recce is so obvious why are there so many other research efforts ongoing? We hope we have a solution but it's early days. I have faith but hell I keep an eye on other efforts. Look at the recent antimicrobial conference where recce bought a speaking spot, many organisations are working in the same space. Why would Monash uni work on a 'solution' that has no prospects because @Bpharma says is already discounted? I'm hoping for a different world view now that Trump is on the way out, one based on science facts and results.
Add to My Watchlist
What is My Watchlist?
 (20min delay)
|
|||||
|
Last
37.5¢ |
Change
0.000(0.00%) |
Mkt cap ! $108.4M | |||
| Open | High | Low | Value | Volume |
| 38.0¢ | 39.0¢ | 36.5¢ | $39.00K | 102.4K |
Buyers (Bids)
| No. | Vol. | Price($) |
|---|---|---|
| 1 | 9999 | 37.5¢ |
Sellers (Offers)
| Price($) | Vol. | No. |
|---|---|---|
| 39.0¢ | 2108 | 1 |
View Market Depth
| Last trade - 16.10pm 08/08/2025 (20 minute delay) ? |
| RCE (ASX) Chart |